Stratos Wealth Advisors LLC Raises Holdings in Colgate-Palmolive (NYSE:CL)

Posted by on Mar 30th, 2023

Stratos Wealth Advisors LLC grew its position in Colgate-Palmolive (NYSE:CL – Get Rating) by 1.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,273 shares of the company’s stock after purchasing an additional 137 shares during the quarter. Stratos Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $652,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. S.E.E.D. Planning Group LLC grew its holdings in shares of Colgate-Palmolive by 11.0% during the fourth quarter. S.E.E.D. Planning Group LLC now owns 4,174 shares of the company’s stock valued at $329,000 after buying an additional 414 shares during the last quarter. Crossmark Global Holdings Inc. grew its holdings in shares of Colgate-Palmolive by 5.1% during the fourth quarter. Crossmark Global Holdings Inc. now owns 72,597 shares of the company’s stock valued at $5,720,000 after buying an additional 3,522 shares during the last quarter. Arlington Partners LLC grew its holdings in shares of Colgate-Palmolive by 175.7% during the fourth quarter. Arlington Partners LLC now owns 1,847 shares of the company’s stock valued at $146,000 after buying an additional 1,177 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its position in Colgate-Palmolive by 22.0% during the fourth quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 22,682 shares of the company’s stock valued at $1,787,000 after purchasing an additional 4,093 shares during the period. Finally, FSM Wealth Advisors LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at $209,000. 77.63% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $74.47 on Thursday. The company has a market cap of $61.84 billion, a PE ratio of 34.96, a price-to-earnings-growth ratio of 3.82 and a beta of 0.48. Colgate-Palmolive has a 12 month low of $67.84 and a 12 month high of $83.81. The company has a debt-to-equity ratio of 10.84, a current ratio of 1.28 and a quick ratio of 0.76. The company has a 50-day simple moving average of $73.47 and a 200-day simple moving average of $74.76.

Colgate-Palmolive (NYSE:CL – Get Rating) last released its quarterly earnings data on Friday, January 27th. The company reported $0.77 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.77. Colgate-Palmolive had a net margin of 9.93% and a return on equity of 317.08%. The company had revenue of $4.63 billion during the quarter, compared to the consensus estimate of $4.58 billion. During the same period in the previous year, the firm earned $0.79 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 5.1% on a year-over-year basis. On average, equities analysts anticipate that Colgate-Palmolive will post 3.1 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, May 15th. Stockholders of record on Friday, April 21st will be given a dividend of $0.48 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date of this dividend is Thursday, April 20th. Colgate-Palmolive’s payout ratio is presently 88.26%.

Analyst Upgrades and Downgrades

CL has been the subject of several research analyst reports. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Friday, March 24th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Colgate-Palmolive from $84.00 to $80.00 in a report on Monday, March 20th. Citigroup started coverage on shares of Colgate-Palmolive in a research report on Thursday, February 16th. They set a “buy” rating and a $84.00 target price for the company. TheStreet cut shares of Colgate-Palmolive from a “b” rating to a “c+” rating in a research report on Friday, January 27th. Finally, Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $80.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, January 30th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $82.27.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Get Rating).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.